Updates on The Management of AMD and RVO: An Evidence-based Approach
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Details
Overview
This certified CME activity is designed for retina specialists and general ophthalmologists involved in the management of retinal disease.Jointly sponsored by The Dulaney Foundation and Retina Today. Supported by an unrestricted educational grant from Regeneron This continuing medical educational activity is supported by an unrestricted educational grant from Regeneron. Learning Objectives
Upon completion of this activity, the participant should be able to: - recognize various forms of macular edema and inflammation, using the latest developments in the medical literature and new insights from case-based learning;
- understand the new data available on treatments for AMD and RVO and how to apply this information in monotherapy and combination therapy treatment schemes; and
- treat various forms of macular edema and inflammation, based on assessment of patient need, latest developments in the medical literature and insights from case-based learning.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Dulaney Foundation and Retina Today. The Dulaney Foundation is accredited by the ACCME to provide continuing education for physicians. The Dulaney Foundation designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participation Method
After reviewing the material, please complete the self-assessment test, which consists of a series of multiple-choice questions. To answer these questions online and receive realtime results, please visit http://www.dulaneyfoundation.org and click “Online Courses.” Upon completing the activity and achieving a passing score of over 70% on the self-assessment test, you may print out a CME credit letter awarding 1 AMA PRA Category 1 Credit.™ The estimated time to complete this activity is 1 hour. Faculty and Disclosures
DISCLOSURE POLICY
Brandon G. Busbee, MD, is with Tennessee Retina, which is based in Nashville. Richard S. Kaiser, MD, is an Associate Surgeon at Wills Eye Hospital, an Associate Professor of Ophthalmology at Thomas Jefferson University Hospital, and a partner in Mid Atlantic Retina. Baruch D. Kuppermann, MD, PhD, is Professor, Chief of the Retina Service, and Vice Chairman of Clinical Research at the Gavin Herbert Eye Institute in the Department of Ophthalmology, University of California, Irvine. Carl D. Regillo, MD, is the Director of the Retina Service of Wills Eye Institute and a Professor of Ophthalmology at Jefferson Medical College of Thomas Jefferson University Hospital in Philadelphia, and a partner in Mid Atlantic Retina. <p><b>FACULTY/STAFF DISCLOSURE DECLARATIONS</b> Dr. Busbee states that he receives grants/research support from Genentech and Regeneron Pharmaceuticals, Inc.; is a consultant to Synergetics, Genentech, Regeneron Pharmaceuticals, Inc., and Thrombogenics; is a speaker for Genentech, Regeneron Pharmaceuticals, Inc., and Thrombogenics; and receives royalty payments from Akorn. Dr. Kaiser states that he receives grants/research support from Wills Eye Research Fund and J Arch McNamara Research Fund; is a consultant to Pan Optica and Regeneron Pharmaceuticals, Inc.; and is a stock/shareholder in Ophthotech. Dr. Kuppermann states that he is a consultant to Alimera Sciences; Allegro Ophthalmolics; Allergan, Inc.; Fovea Pharmaceuticals; Glaukos Corporation; Neurotech Pharmaceuticals; Novagali Pharma; Novartis Pharmaceuticals; OptoTech, Regeneron Pharmaceuticals, Inc.; Santen; Second Sight; Teva Pharmaceuticals; and Thrombogenics. Dr. Regillo states that he receives grant research support from Allergan, Inc.; Genentech; GlaxoSmithKline; Opthotech; and Regeneron Pharmaceuticals, Inc.; and that he is a consultant to Genentech; GlaxoSmithKline; and Regeneron Pharmaceuticals, Inc. All of those involved in the planning, editing, and peer review of this educational activity report no relevant financial relationships.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
In accordance with the disclosure policies of The Dulaney Foundation and to conform with ACCME and US Food and Drug Administration guidelines, anyone in a position to affect the content of a CME activity is required to disclose to the activity participants (1) the existence of any financial interest or other relationships with the manufacturers of any commercial products/ devices or providers of commercial services and (2) identification of a commercial product/device that is unlabeled for use or an investigational use of a product/ device not yet approved. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
1.00 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- MinuteCE®
Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
1.00 program credit
Janis T. Eells, Ph.D.
Diana V. Do, MD
David Boyer, MD
Marion Munk, MD, Ph.D
David Boyer, MD
Diana V. Do, MD
Marion Munk, MD, Ph.D
